This loss consisted of the following: (i) loss of $8.5 million driven by ongoing litigation costs and settlements related to the DeVry University divestiture, partially offset by income from the DeVry University earn-out; (ii) a loss on the sale of ACAMS, Becker, and OCL of $3.6 million for working capital adjustments to the initial sales price and a tax return to provision adjustment; and (iii) a benefit from income taxes of $3.6 million associated with the items listed above.
This loss consisted of the following: (i) loss of $8.5 million driven by ongoing litigation costs and settlements related to the DeVry University divestiture, partially offset by income from the DeVry University earn-out; (ii) loss on the sale of ACAMS, Becker, and OCL of $3.6 million for working capital adjustments to the initial sales prices and a tax return to provision adjustment; and (iii) benefit from income taxes of $3.6 million associated with the items listed above.
Credit Losses The allowance for credit losses represents an estimate of the lifetime expected credit losses inherent in our accounts receivable balances as of each balance sheet date. In evaluating the collectability of all our accounts receivable balances, we utilize historical events, current conditions, and reasonable and supportable forecasts about the future.
Credit Losses The allowance for credit losses represents an estimate of the lifetime expected credit losses inherent in our accounts and financing receivable balances as of each balance sheet date. In evaluating the collectability of our accounts and financing receivable balances, we utilize historical events, current conditions, and reasonable and supportable forecasts about the future.
Tuition Rates: On a per credit hour basis, tuition for Walden programs range from $130 per credit hour to $1,060 per credit hour, with the wide range due to the nature of the programs. General education courses are charged at $333 per credit hour.
Tuition Rates: On a per credit hour basis, tuition for Walden programs range from $130 per credit hour to $1,060 per credit hour, with the wide range due to the nature of the programs. General education courses are charged at $340 per credit hour.
“Financial Statements and Supplementary Data.” Non-GAAP Financial Measures and Reconciliations We believe that certain non-GAAP financial measures provide investors with useful supplemental information regarding the underlying business trends and performance of Adtalem’s ongoing operations as seen through the eyes of management and are useful for period-over-period comparisons.
“Financial Statements and Supplementary Data.” 49 Table of Contents Non-GAAP Financial Measures and Reconciliations We believe that certain non-GAAP financial measures provide investors with useful supplemental information regarding the underlying business trends and performance of Adtalem’s ongoing operations as seen through the eyes of management and are useful for period-over-period comparisons.
If economic conditions deteriorate, interest rates continue to rise, or operating performance of our reporting units do not meet expectations such that we revise our long-term forecasts, we may recognize impairments of goodwill and other intangible assets in future periods. See Note 71 Table of Contents 13 “Goodwill and Intangible Assets” to the Consolidated Financial Statements in Item 8.
If economic conditions deteriorate, interest rates rise, or operating performance of our reporting units do not meet expectations such that we revise our long-term forecasts, we may recognize impairments of goodwill and other intangible assets in future periods. See Note 13 “Goodwill and Intangible Assets” to the Consolidated Financial Statements in Item 8.
“Financial Statements and Supplementary Data” for additional information on our credit losses. 70 Table of Contents Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
“Financial Statements and Supplementary Data” for additional information on our credit losses. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
This measure is applied on a consolidated and segment basis, depending on the context of the discussion. Income taxes, interest expense, and other income, net is not recorded at the reportable segments, and therefore, the segment adjusted EBITDA reconciliations begin with operating income (loss).
This measure is applied on a consolidated and segment basis, depending on the context of the discussion. Provision for income taxes, interest expense, and other income, net is not recorded at the reportable segments, and therefore, the segment adjusted EBITDA reconciliations begin with operating income.
The respective tuition rates for AUC, RUSM, and RUSVM do not include the cost of transportation, living expenses, or health insurance. Cost of Educational Services The largest component of cost of educational services is the cost of faculty and staff who support educational operations.
The respective tuition rates for AUC, RUSM, and RUSVM do not include the cost of transportation, living expenses, or health insurance. 40 Table of Contents Cost of Educational Services The largest component of cost of educational services is the cost of faculty and staff who support educational operations.
Intangible assets with finite lives are amortized over their expected economic lives, ranging from 3 to 5 years. All intangible assets and certain goodwill are being amortized for tax reporting purposes over statutory lives. Determining the fair value of a reporting unit or an intangible asset involves the use of significant estimates and assumptions.
Intangible assets with finite lives are amortized over their expected economic lives, ranging from three to five years. All intangible assets and certain goodwill are being amortized for tax reporting purposes over statutory lives. Determining the fair value of a reporting unit or an intangible asset involves the use of significant estimates and assumptions.
See the “Non-GAAP Financial Measures and Reconciliations” section for the reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures. Certain items presented in tables may not sum due to rounding. Percentages presented are calculated from the underlying numbers in thousands.
See the “Non-GAAP Financial Measures and Reconciliations” 36 Table of Contents section for the reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures. Certain items presented in tables may not sum due to rounding. Percentages presented are calculated from the underlying numbers in thousands.
Based on this quantitative assessment, it was determined that the fair value of the Walden reporting unit exceeded its carrying value by approximately 15% and therefore no goodwill impairment was identified. Significant judgments and assumptions were used in determining the fair value of intangible assets.
Based on this quantitative assessment, it was determined that the fair value of the AUC reporting unit exceeded its carrying value by approximately 20% and therefore no goodwill impairment was identified. Significant judgments and assumptions were used in determining the fair value of intangible assets.
This gain was recorded at Adtalem’s home office, which is classified as “Home Office and Other” in Note 22 “Segment Information” to the Consolidated Financial Statements in Item 8.
This gain was recorded at Adtalem’s home office, which is classified as “Home Office” in Note 22 “Segment Information” to the Consolidated Financial Statements in Item 8.
The estimate of our credit losses involves a significant level of uncertainty as it requires significant judgment to estimate the amount we will collect in the future on our account receivable balances. See Note 10 “Accounts Receivable and Credit Losses” to the Consolidated Financial Statements in Item 8.
The estimate of our credit losses involves a significant level of uncertainty as it requires significant judgment to estimate the amount we will collect in the future on our accounts and financing receivable balances. See Note 10 “Accounts and Financing Receivables” to the Consolidated Financial Statements in Item 8.
Some programs require students to attend residencies, skills labs, and pre-practicum labs, which are charged at a range of $1,000 to $2,550 per event. In most cases, these tuition rates, event charges, and fees represent increases of approximately 3.0% to 6.6% from the prior year.
Some programs require students to attend residencies, skills labs, and pre-practicum labs, which are charged at a range of $1,000 to $2,550 per event. In most cases, these tuition rates, event charges, and fees represent increases of approximately 0% to 4% with an average of approximately 2% from the prior year.
The Revolver will be used to finance ongoing working capital and for general corporate purposes. During fiscal year 2022, we made a prepayment of $396.7 million on the Term Loan B. With that prepayment, we are no longer required to make quarterly installment payments.
We refer to the Term Loan B and Revolver collectively as the “Credit Facility.” The Revolver will be used to finance ongoing working capital and for general corporate purposes. During fiscal year 2022, we made a prepayment of $396.7 million on the Term Loan B. With that prepayment, we are no longer required to make quarterly installment payments.
In the U.S., Adtalem has posted $31.9 million of surety bonds with regulatory authorities on behalf of Chamberlain, Walden, AUC, RUSM, and RUSVM. Operating Lease Obligations – We have operating lease obligations for the minimum payments required under various lease agreements which are recorded on the Consolidated Balance Sheets.
In the U.S., Adtalem has posted $44.3 million of surety bonds as of June 30, 2024 with regulatory authorities on behalf of Chamberlain, Walden, AUC, RUSM, and RUSVM. Operating Lease Obligations – We have operating lease obligations for the minimum payments required under various lease agreements which are recorded on the Consolidated Balance Sheets.
During fiscal year 2023 and 2022, we received proceeds from the sale of marketable securities held in a Rabbi Trust of $7.6 million and $3.4 million, respectively, and made additional investments in marketable securities held by this trust of $1.5 million and $3.6 million, respectively.
During fiscal year 2024 and 2023, we received proceeds from the sale of marketable securities held in a Rabbi Trust of $1.7 million and $7.6 million, respectively, and made additional investments in marketable securities held by the Rabbi Trust of $0.7 million and $1.5 million, respectively.
Other programs such as those with a subscription-based learning modality or those billed on a subscription period or term basis range from $1,500 to $7,180 per term. Students are charged a technology fee that ranges from $50 to $230 per term as well as a clinical fee of $150 per course for specific programs.
Other programs such as those with a subscription-based learning modality or those billed on a subscription period or term basis range from $1,550 to $7,325 per term. Students are charged a program fee that ranges from $50 to $230 per term as well as a clinical fee of $160 per course for specific programs.
Each of these factors and assumptions can significantly affect the value of the intangible asset. Based on these quantitative assessments, it was determined that the fair values of these indefinite-lived intangible assets in the Walden reporting unit exceeded their carrying values by approximately 10% and no impairment was identified.
Each of these factors and assumptions can significantly affect the value of the intangible asset. Based on these quantitative assessments, it was determined that the fair values of these indefinite-lived intangible assets in the AUC reporting unit exceeded their carrying values by at least 23% and therefore no impairment was identified.
If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset or asset group, the amount of the impairment is the difference between the carrying amount and the fair value of the asset or asset group.
Upon identifying such an event, if the carrying value of the long-lived asset is no longer recoverable based upon the undiscounted future cash flows of the asset or asset group, the amount of the impairment is the difference between the carrying amount and the fair value of the asset or asset group.
The with and without method of the income approach and the relief from royalty model used in the determination of the fair values of our Walden Title IV eligibility and trade name intangible assets, respectively, during 2023 reflected our most recent revenue projections, a discount rate of 12.5%, a royalty rate of 2.25% and terminal growth rates of 3%.
The with and without method of the income approach and the relief from royalty model used in the determination of the fair values of our AUC Title IV eligibility and trade name intangible assets, respectively, during fiscal year 2024 reflected our most recent revenue projections, a discount rate of 12.5%, a royalty rate of 5.5%, and a terminal growth rate of 3.0%.
As of June 30, 2023, $172.7 million of authorized share repurchases were remaining under the current share repurchase program. The timing and amount of any 68 Table of Contents future repurchases will be determined based on an evaluation of market conditions and other factors. See Note 16 “Share Repurchases” to the Consolidated Financial Statements in Item 8.
As of June 30, 2024, $211.6 million of authorized share repurchases were remaining under the fourteenth share repurchase program. The timing and amount of any future repurchases will be determined based on an evaluation of market conditions and other factors. See Note 16 “Share Repurchases” to the Consolidated Financial Statements in Item 8.
“Financial Statements and Supplementary Data”) by entering into its new credit agreement (the “Credit Agreement”) that provides for (1) a $850.0 million senior secured term loan (“Term Loan B”) with a maturity date of August 12, 2028 and (2) a $400.0 million senior secured revolving loan facility (“Revolver”) with a maturity date of August 12, 2026.
On August 12, 2021, Adtalem entered into its new credit agreement (the “Credit Agreement”) that provides for (1) a $850.0 million senior secured term loan (“Term Loan B”) with a maturity date of August 12, 2028 and (2) a $400.0 million senior secured revolving loan facility (“Revolver”) with a maturity date of August 12, 2026.
Management anticipates fiscal year 2024 capital spending to be in the $50 to $60 million range. The source of funds for this capital spending will be from operations or the Credit Facility (as defined and discussed in Note 14 “Debt” to the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data”).
The source of funds for this capital spending will be from operations or the Credit Facility (as defined and discussed in Note 14 “Debt” to the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data”).
The discounted cash flow models used to determine the fair value of our Walden reporting unit during 2023 reflected our most recent cash flow projections, a discount rate of 12.5% and terminal growth rates of 3%. Each of these inputs can significantly affect the fair values of our reporting units.
The discounted cash flow models used to determine the fair value of our AUC reporting unit during fiscal year 2024 reflected our most recent cash 48 Table of Contents flow projections, a discount rate of 12.5%, and a terminal growth rate of 3.0%. Each of these inputs can significantly affect the fair values of our reporting units.
These tuition rates represent a 5.0% increase from the prior academic year. Effective for semesters beginning in September 2022, for students first enrolled in May 2022 and after, tuition rates for the beginning basic sciences and final clinical rotation portions of RUSM’s medical program are $21,966 and $25,893, respectively, per semester.
These tuition rates represent a 6.0% increase from the prior academic year. Effective for semesters beginning in September 2023, for students first enrolled in May 2022 and after, tuition rates for the beginning basic sciences and clinical rotation portions of RUSM’s medical program are $23,284 and $27,447, respectively, per semester.
The following are non-GAAP financial measures used in this Annual Report on Form 10-K: Adjusted net income (most comparable GAAP measure: net income attributable to Adtalem) – Measure of Adtalem’s net income attributable to Adtalem adjusted for deferred revenue adjustment, CEO transition costs, restructuring expense, business acquisition and integration expense, intangible amortization expense, gain on sale of assets, pre-acquisition interest expense, write-off of debt discount and issuance costs, gain on extinguishment of debt, litigation reserve, investment impairment, net tax benefit related to a valuation allowance release, and net loss (income) from discontinued operations attributable to Adtalem.
The following are non-GAAP financial measures used in this Annual Report on Form 10-K: Adjusted net income (most comparable GAAP measure: net income) – Measure of Adtalem’s net income adjusted for restructuring expense, business acquisition and integration expense, amortization of acquired intangible assets, gain on sale of assets, write-off of debt discount and issuance costs, gain on extinguishment of debt, litigation reserve, investment impairment, loss on assets held for sale, debt modification costs, tax benefit due to change in valuation allowance, tax benefit due to change in unrecognized tax benefits, and loss from discontinued operations.
In the event of unexpected market conditions or negative economic changes, including those caused by COVID-19, that could negatively affect Adtalem’s earnings and/or operating cash flow, Adtalem maintains a $400.0 million revolving credit facility with availability of $323.8 million as of June 30, 2023.
In the event of unexpected market conditions or negative economic changes that could negatively affect Adtalem’s earnings and/or operating cash flow, Adtalem maintains a $400.0 million revolving credit facility with availability of $242.1 million as of June 30, 2024.
Adtalem’s consolidated cash and cash equivalents balance of $273.7 million and $347.0 million as of June 30, 2023 and 2022, respectively, included cash and cash equivalents held at Adtalem’s international operations of $7.2 million and $34.2 million as of June 30, 2023 and 2022, respectively, which is available to Adtalem for general corpora te purposes.
Adtalem’s consolidated cash and cash equivalents balance of $219.3 million and $272.2 million as of June 30, 2024 and 2023, respectively, included cash and cash equivalents held at Adtalem’s international operations of $4.6 million and $7.2 million as of June 30, 2024 and 2023, respectively, which is available to Adtalem for general corpora te purposes.
As of June 30, 2023, total student enrollment at Walden decreased 4.8% compared to June 30, 2022. ● For fiscal year 2023, average total student enrollment at the medical and veterinary schools decreased 1.0% compared to the prior year .
As of June 30, 2024, total student enrollment at Walden increased 11.3% compared to June 30, 2023. ● For fiscal year 2024, average total student enrollment at the medical and veterinary schools decreased 5.1% compared to the prior year .
Walden Walden Student Enrollment: Fiscal Year 2023 September 30, December 31, March 31, June 30, Period 2022 2022 2023 2023 Total students 40,772 37,956 39,427 37,582 % change from prior year (9.2) % (7.8) % (7.9) % (4.8) % Fiscal Year 2022 September 30, December 31, March 31, June 30, Period 2021 2021 2022 2022 Total students 44,886 41,158 42,788 39,470 51 Table of Contents Walden total student enrollment represents those students attending instructional sessions as of the dates identified above.
Walden Walden Student Enrollment: Fiscal Year 2024 September 30, December 31, March 31, June 30, Period 2023 2023 2024 2024 Total students 40,975 40,971 42,751 41,845 % change from prior year 0.5 % 7.9 % 8.4 % 11.3 % Fiscal Year 2023 September 30, December 31, March 31, June 30, Period 2022 2022 2023 2023 Total students 40,772 37,956 39,427 37,582 % change from prior year (9.2) % (7.8) % (7.9) % (4.8) % Walden total student enrollment represents those students attending instructional sessions as of the dates identified above.
“Financial Statements and Supplementary Data” and the notes thereto but not presented in accordance with U.S. generally 46 Table of Contents accepted accounting principles (“GAAP”). Certain of these items are considered “non-GAAP financial measures” under the Securities and Exchange Commission (“SEC”) rules.
Throughout this MD&A, we sometimes use information derived from the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data” and the notes thereto but not presented in accordance with U.S. generally accepted accounting principles (“GAAP”). Certain of these items are considered “non-GAAP financial measures” under the Securities and Exchange Commission (“SEC”) rules.
In addition, we continue to incur costs associated with ongoing litigation and settlements related to the DeVry University divestiture, which was completed during fiscal year 2019, and are classified as expense within discontinued operations. Net loss from discontinued operations in the year ended June 30, 2023 was $8.4 million.
In addition, we continue to incur costs associated with ongoing litigation and settlements related to the DeVry University and Carrington College divestitures, which were completed during fiscal year 2019, and are classified as expense within discontinued operations. Loss from discontinued operations in fiscal year 2024 was $0.9 million.
Adjusted EBITDA (most comparable GAAP measure: net income attributable to Adtalem) – Measure of Adtalem’s net income attributable to Adtalem adjusted for net loss (income) from discontinued operations attributable to Adtalem, interest expense, other income, net, provision for (benefit from) income taxes, depreciation and amortization, stock-based compensation, deferred revenue adjustment, CEO transition costs, restructuring expense, business acquisition and integration expense, litigation reserve, and gain on sale of assets.
Adjusted EBITDA (most comparable GAAP measure: net income) – Measure of Adtalem’s net income adjusted for loss from discontinued operations, interest expense, other income, net, provision for income taxes, depreciation, amortization of acquired intangible assets, amortization of cloud computing implementation assets, stock-based compensation, restructuring expense, business acquisition and integration expense, litigation reserve, loss on assets held for sale, debt modification costs, and gain on sale of assets.
Recent Accounting Pronouncements For a discussion of recent accounting pronouncements, see Note 2 “Summary of Significant Accounting Policies” to the Consolidated Financial Statements in Item 8.
“Financial Statements and Supplementary Data” for additional information on our loss contingencies. Recent Accounting Pronouncements For a discussion of recent accounting pronouncements, see Note 2 “Summary of Significant Accounting Policies” to the Consolidated Financial Statements in Item 8.
These tuition rates represent a 5.0% increase from the prior academic year. Effective for semesters beginning in September 2022, for students first enrolled in May 2022 and after, tuition rates for the beginning basic sciences and final clinical rotation portions of AUC’s medical program are $20,202 and $25,116, respectively, per semester.
Effective for semesters beginning in September 2023, for students first enrolled in May 2022 and after, tuition rates for the beginning basic sciences and clinical rotation portions of AUC’s medical program are $21,568 and $28,146, respectively, per semester, which represents a 6.8% and 12.0% increase, respectively, from the prior academic year.
We recorded a note receivable of $40.3 million and a financing payable of $45.5 million at the time of the sale, which were classified as other assets, net and other liabilities, respectively, on the Consolidated Balance Sheets. On February 23, 2023, DePaul College Prep paid the mortgage in full.
Adtalem continued to maintain the assets associated with the sale on the Consolidated Balance Sheets. We recorded a note receivable of $40.3 million and a financing payable of $45.5 million at the time of the sale, which were classified as other assets, net and other liabilities, respectively, on the Consolidated Balance Sheets.
We received an initial delivery of 4,709,576 shares of common stock. The ASR agreement ended on October 14, 2022. Based on the volume-weighted average price of Adtalem’s common stock during the term of the ASR agreement, Adtalem owed the counter party 332,212 shares of common stock.
Based on the volume-weighted average price of Adtalem’s common stock during the term of the ASR agreement, Adtalem owed the counter party 332,212 shares of common stock.
On April 11, 2022, we repaid $373.3 million of Notes at a price equal to 100% of the principal amount of the Notes.
On April 11, 2022, we repaid $373.3 million of Notes at a price equal to 100% of the principal amount of the Notes. During June 2022, we repurchased on the open market an additional $20.8 million of Notes at a price equal to approximately 90% of the principal amount of the Notes.
Chamberlain Chamberlain operating income increased 8.3%, or $10.3 million, to $134.7 million in fiscal year 2023 compared to the prior year. Segment adjusted operating income increased 6.5%, or $8.3 million, to $135.5 million in fiscal year 2023 compared to the prior year.
Chamberlain Chamberlain operating income increased 2.3%, or $3.1 million, to $137.8 million in fiscal year 2024 compared to the prior year. Segment adjusted operating income increased 1.7%, or $2.3 million, to $137.8 million in fiscal year 2024 compared to the prior year.
Medical and Veterinary Medical and Veterinary operating income increased 0.5%, or $0.3 million, to $59.6 million in fiscal year 2023 compared to the prior year. Segment adjusted operating income decreased 2.6%, or $1.8 million, to $67.3 million in fiscal year 2023 compared to the prior year.
Medical and Veterinary Medical and Veterinary operating income increased 19.1%, or $11.4 million, to $71.1 million in fiscal year 2024 compared to the prior year. Segment adjusted operating income increased 6.2%, or $4.2 million, to $71.5 million in fiscal year 2024 compared to the prior year.
Critical accounting estimates discussed below are those that we believe involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition or results of operations. Management has discussed our critical accounting estimates with the Audit and Finance Committee of the Board.
Critical accounting estimates discussed below are those that we believe involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial 47 Table of Contents condition or results of operations. Although management believes its assumptions and estimates are reasonable, actual results could differ from those estimates.
For the May 2023 session, total student enrollment at Chamberlain increased 1.2% compared to the same session last year. ● For fiscal year 2023, average total student enrollment at Walden decreased 7.5% compared to the prior year .
For the May 2024 session, total student enrollment at Chamberlain increased 10.4% compared to the same session last year. ● For fiscal year 2024, average total student enrollment at Walden increased 6.9% compared to the prior year .
As of June 30, 2023, the amount of debt outstanding under the Notes and Credit Facility was $708.3 million. See Note 14 “Debt” to the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data” for additional information on the Notes and our Credit Agreement.
See Note 14 “Debt” to the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data” for additional information on the Notes and our Credit Agreement.
Adjusted earnings per share (most comparable GAAP measure: earnings per share) – Measure of Adtalem’s diluted earnings per share adjusted for deferred revenue adjustment, CEO transition costs, restructuring expense, business acquisition and integration expense, intangible amortization expense, gain on sale of assets, pre-acquisition interest expense, write-off of debt discount and issuance costs, gain on extinguishment of debt, litigation reserve, investment impairment, net tax benefit related to a valuation allowance release, and net loss (income) from discontinued operations attributable to Adtalem. 72 Table of Contents Adjusted operating income (most comparable GAAP measure: operating income) – Measure of Adtalem’s operating income adjusted for deferred revenue adjustment, CEO transition costs, restructuring expense, business acquisition and integration expense, intangible amortization expense, litigation reserve, and gain on sale of assets.
Adjusted earnings per share (most comparable GAAP measure: diluted earnings per share) – Measure of Adtalem’s diluted earnings per share adjusted for restructuring expense, business acquisition and integration expense, amortization of acquired intangible assets, gain on sale of assets, write-off of debt discount and issuance costs, gain on extinguishment of debt, litigation reserve, investment impairment, loss on assets held for sale, debt modification costs, tax benefit due to change in valuation allowance, tax benefit due to change in unrecognized tax benefits, and loss from discontinued operations.
Tuition for the online Family Nurse Practitioner (“FNP”) degree program is $690 per credit hour. Tuition for the online Doctor of Nursing Practice (“DNP”) degree program is $800 per credit hour. Tuition for the online Master of Public Health (“MPH”) degree program is $550 per credit hour.
Tuition for the online Master of Science in Nursing (“MSN”) degree program is $695 per credit hour. Tuition for the online Family Nurse Practitioner (“FNP”) degree program is $710 per credit hour. Tuition for the online Doctor of Nursing Practice (“DNP”) degree program is $806 per credit hour.
These tuition rates do not include the cost of course fees, books, supplies, transportation, clinical fees, living expenses, or other fees as listed in the Chamberlain academic catalog.
In most cases, these tuition rates represent increases of approximately 0% to 8% with an average of approximately 4% from the prior year. These tuition rates do not include the cost of course fees, books, supplies, transportation, clinical fees, living expenses, or other fees as listed in the Chamberlain academic catalog.
Financing Activities The following table provides a summary of cash flows from financing activities (in thousands): Year Ended June 30, 2023 2022 Repurchases of common stock for treasury $ (123,133) $ (120,000) Payment on equity forward contract (13,162) (30,000) Net repayments of long-term debt (150,861) (229,713) Payment of debt discount and issuance costs — (49,553) Payment for purchase of redeemable noncontrolling interest of subsidiary — (1,790) Other (1,359) 6,580 Net cash used in financing activities $ (288,515) $ (424,476) On November 8, 2018, we announced that the Board authorized Adtalem’s eleventh share repurchase program, which allowed Adtalem to repurchase up to $300.0 million of its common stock through December 31, 2021.
Financing Activities The following table provides a summary of cash flows from financing activities (in thousands): Year Ended June 30, 2024 2023 Repurchases of common stock for treasury $ (261,966) $ (123,133) Payment on equity forward contract — (13,162) Net repayments of long-term debt (50,000) (150,861) Other 10,168 (1,359) Net cash used in financing activities $ (301,798) $ (288,515) On March 1, 2022, we announced that the Board authorized Adtalem’s thirteenth share repurchase program, which allows Adtalem to repurchase up to $300.0 million of its common stock through February 25, 2025.
Tuition for the online Master of Social Work (“MSW”) degree program is $695 per credit hour. Tuition for the onsite Master of Physician Assistant Studies (“MPAS”) is $8,000 per session. Some of these tuition rates increased by 3% to 4% from the prior year.
Tuition for the online Master of Public Health (“MPH”) degree program is $590 per credit hour. Tuition for the online Master of Social Work (“MSW”) degree program is $695 per credit hour. Tuition for the onsite Master of Physician Assistant Studies (“MPAS”) is $8,000 per session.
This income consisted of the following: (i) loss of $1.0 million driven by ongoing litigation costs and settlements related to the DeVry University divestiture, partially offset by the operating results related to ACAMS, Becker, OCL, and EduPristine, and income from the DeVry University earn-out; (ii) a gain on the sale of ACAMS, Becker, OCL, and EduPristine of $473.5 million; and (iii) a provision for income taxes of $125.6 million associated with the items listed above.
This loss consisted of the following: (i) loss of $0.8 million driven by ongoing litigation costs and settlements related to the DeVry University and Carrington College divestitures, partially offset by income from the DeVry University earn-out; and (ii) provision for income taxes of $0.2 million associated with the items listed above.
While we believe that the amount accrued to-date is adequate, future changes in circumstances could impact these determinations. See Note 21 “Commitments and Contingencies” to the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data” for additional information on our loss contingencies.
The valuation of liabilities for these contingencies is reviewed on a quarterly basis and any necessary adjustments to the accrual on the Consolidated Balance Sheets is recorded. While we believe that the amount accrued to-date is adequate, future changes in circumstances could impact these determinations. See Note 21 “Commitments and Contingencies” to the Consolidated Financial Statements in Item 8.
Adtalem received $5.2 million of cash at the time of closing and held a mortgage loan, secured by the property, from DePaul College Prep for $46.8 million. The mortgage loan was due on July 31, 2024 as a balloon payment and bore interest at a rate of 4% per annum, payable monthly. The buyer had an option to make prepayments.
The mortgage loan was due on July 31, 2024 as a balloon payment and bore interest at a rate of 4% per annum, payable monthly. The buyer had an option to make prepayments. On February 23, 2023, DePaul College Prep paid the mortgage loan in full.
Adtalem received $5.2 million of cash at the time of closing and held a mortgage, secured by the property, from DePaul College Prep for $46.8 million. The mortgage was due on July 31, 2024 as a balloon payment and bore interest at a rate of 4% per annum, payable monthly. DePaul College Prep had an option to make prepayments.
The mortgage was due on July 31, 2024 as a balloon payment and bore interest at a rate of 4% per annum, payable monthly. DePaul College Prep had an option to make prepayments. Due to Adtalem’s involvement with financing the sale, the transaction did not qualify as a sale for accounting purposes at the time of closing.
A description of special items in our non-GAAP financial measures described above are as follows: ● Deferred revenue adjustment related to a revenue purchase accounting adjustment to record Walden’s deferred revenue at fair value. ● CEO transition costs related to acceleration of stock-based compensation expense. ● Restructuring expense primarily related to plans to achieve synergies with the Walden acquisition and real estate consolidations at Walden, Medical and Veterinary, and Adtalem’s home office.
A description of special items in our non-GAAP financial measures described above are as follows: ● Restructuring expense primarily related to real estate consolidations at Walden, Medical and Veterinary, and Adtalem’s home office.
The decrease of $9.8 million in cash generated from changes in assets and liabilities was primarily due to timing differences in accounts receivable, prepaid assets, prepaid income taxes, accounts payable, accrued payroll and benefits, accrued liabilities, accrued interest, and deferred revenue. Investing Activities Capital expenditures in fiscal year 2023 were $37.0 million compared to $31.1 million in the prior year.
The increase of $50.9 million in cash generated from changes in assets and liabilities between fiscal year 2024 and 2023 was primarily due to timing differences in accounts and financing receivables, prepaid assets, cloud computing implementation assets, accounts payable, accrued payroll and benefits, accrued liabilities, accrued interest, and deferred revenue. 45 Table of Contents Investing Activities Capital expenditures were $48.9 million and $26.0 million in fiscal year 2024 and 2023, respectively.
These are transaction costs associated with acquiring Walden and costs associated with integrating Walden into Adtalem. In addition, during fiscal year 2023, we initiated transformation initiatives to accelerate growth and organizational agility. Certain costs relating to this transformation are included in business acquisition and integration costs in the Consolidated Statements of Income.
Business Acquisition and Integration Expense Business acquisition and integration expense was $34.2 million and $42.7 million in fiscal year 2024 and 2023, respectively. These are costs associated with integrating Walden into Adtalem. In addition, during fiscal year 2023, we initiated transformation initiatives to accelerate growth and organizational agility.
In addition, in fiscal year 2023, we recorded a net tax benefit of $6.4 million for the release of a valuation allowance on certain deferred tax assets based on our reassessment of the amount of state net operating loss carryforwards that are more likely than not to be realized.
In addition, in fiscal year 2023, we released a valuation allowance on certain deferred tax assets based on our reassessment of the amount of state net operating loss carryforwards that are more likely than not to be realized. 44 Table of Contents Discontinued Operations Beginning in the second quarter of fiscal year 2022, ACAMS, Becker, OCL, and EduPristine operations were classified as discontinued operations.
Cash Flow Summary Operating Activities The following table provides a summary of cash flows from operating activities (in thousands): Year Ended June 30, 2023 2022 Income (loss) from continuing operations $ 101,752 $ (35,955) Non-cash items 196,924 283,158 Changes in assets and liabilities (92,992) (83,201) Net cash provided by operating activities-continuing operations $ 205,684 $ 164,002 Net cash provided by operating activities from continuing operations in fiscal year 2023 was $205.7 million compared to $164.0 million in the prior year.
Cash Flow Summary Operating Activities The following table provides a summary of cash flows from operating activities (in thousands): Year Ended June 30, 2024 2023 Income from continuing operations $ 137,713 $ 101,752 Non-cash items 203,567 196,725 Changes in assets and liabilities (52,913) (103,787) Net cash provided by operating activities-continuing operations $ 288,367 $ 194,690 Net cash provided by operating activities from continuing operations in fiscal year 2024 was $288.4 million compared to $194.7 million in the prior year.
Adtalem reduces its net tax assets for the estimated additional tax and interest that may result from tax authorities disputing uncertain tax positions Adtalem has taken. Contingencies Adtalem is subject to contingencies, such as various claims and legal actions that arise in the normal conduct of its business.
Adtalem is subject to audit by federal, state, and foreign tax authorities and Adtalem reduces its net tax assets for the estimated additional tax and interest that may result from those tax authorities disputing uncertain tax positions Adtalem has taken.
Other Income, Net Other income, net in fiscal year 2023 was $7.0 million compared to $1.1 million in the prior year. The increase in other income, net was primarily the result of an increase in interest income, partially offset by a $5.0 million investment impairment of an equity investment.
Other Income, Net Other income, net was income of $10.5 million and income of $7.0 million in fiscal year 2024 and 2023, respectively. The other income, net increase in fiscal year 2024 was primarily driven by $5.0 million of expense in fiscal year 2023 for an impairment of an equity investment.
In addition, students first enrolled in May 2022, and after, pay administrative fees of $5,086 and $3,427 for the basic sciences and final clinical rotation portions of the program, respectively, per semester. ● Effective for semesters beginning in September 2022, for students who first enrolled prior to May 2022, tuition rates for the beginning basic sciences and final clinical rotation portions of RUSM’s medical program are $25,988 and $28,676, respectively, per semester.
In addition, students first enrolled in May 2022 and after are charged administrative fees of $5,430 and $3,841 for the basic sciences and clinical rotation portions of the program, respectively, per semester, which represents a 6.8% and 12.0% increase, respectively, from the prior academic year. ● Effective for semesters beginning in September 2023, for students first enrolled prior to May 2022, tuition rates for the beginning basic sciences and clinical rotation portions of RUSM’s medical program are $27,547 and $30,397, respectively, per semester.
Medical and Veterinary Schools Medical and Veterinary Schools Student Enrollment: Fiscal Year 2023 Semester Sept. 2022 Jan. 2023 May 2023 Total students 5,634 5,312 4,869 % change from prior year 3.4 % 1.6 % (8.2) % Fiscal Year 2022 Semester Sept. 2021 Jan. 2022 May 2022 Total students 5,449 5,228 5,304 % change from prior year (6.9) % (1.2) % 3.5 % Medical and Veterinary revenue increased 2.1%, or $7.2 million, to $346.1 million in fiscal year 2023 compared to the prior year, driven by tuition rate increases at all three institutions in this segment, partially offset by an average total student enrollment decline of 1.0% compared to the prior year and the higher use of scholarships to attract and retain students at AUC and RUSM.
These tuition rates, event charges, and fees do not include the cost of books or personal technology, supplies, transportation, or living expenses. 39 Table of Contents Medical and Veterinary Medical and Veterinary Student Enrollment: Fiscal Year 2024 Semester Sept. 2023 Jan. 2024 May 2024 Total students 5,209 5,073 4,726 % change from prior year (7.5) % (4.5) % (2.9) % Fiscal Year 2023 Semester Sept. 2022 Jan. 2023 May 2023 Total students 5,634 5,312 4,869 % change from prior year 3.4 % 1.6 % (8.2) % Medical and Veterinary revenue increased 2.8%, or $9.7 million, to $355.8 million in fiscal year 2024 compared to the prior year, driven by tuition rate increases at all three institutions in this segment, partially offset by decreased enrollment at all three institutions.
We record an accrual for those matters where management believes a loss is probable and can be reasonably estimated. For those matters for which we have not recorded an accrual, their possible impact on Adtalem’s business, financial condition, or results of operations, cannot be predicted at this time.
For those matters for which we have not recorded an accrual, their possible impact on Adtalem’s business, financial condition, or results of operations, cannot be predicted at this time. A significant amount of judgment and the use of estimates are required to quantify our ultimate exposure in these matters.
The eleventh share repurchase program commenced in January 2019 and was completed in January 2021. On February 4, 2020, we announced that the Board authorized Adtalem’s twelfth share repurchase program, which allowed Adtalem to repurchase up to $300.0 million of its common stock through December 31, 2021.
On January 16, 2024, Adtalem completed its thirteenth share repurchase program. On January 19, 2024, we announced that the Board authorized Adtalem’s fourteenth share repurchase program, which allows Adtalem to repurchase up to $300.0 million of its common stock through January 16, 2027.
Fiscal Year Ended June 30, 2022 Revenue The following table presents revenue by segment detailing the changes from the prior year (in thousands): Year Ended June 30, 2023 Chamberlain Walden Medical and Veterinary Consolidated Fiscal year 2022 $ 557,536 $ 485,393 $ 338,913 $ 1,381,842 Organic growth (decline) 13,498 (15,818) 7,154 4,834 Effect of acquisitions — 64,150 — 64,150 Fiscal year 2023 $ 571,034 $ 533,725 $ 346,067 $ 1,450,826 Fiscal year 2023 % change: Organic growth (decline) 2.4 % (3.3) % 2.1 % 0.3 % Effect of acquisitions — 13.2 % — 4.6 % Fiscal year 2023 % change 2.4 % 10.0 % 2.1 % 5.0 % 50 Table of Contents Chamberlain Chamberlain Student Enrollment: Fiscal Year 2023 Session July 2022 Sept. 2022 Nov. 2022 Jan. 2023 Mar. 2023 May 2023 Total students 31,371 33,153 33,390 34,760 34,847 33,284 % change from prior year (4.1) % (4.0) % (0.8) % 1.8 % 2.0 % 1.2 % Fiscal Year 2022 Session July 2021 Sept. 2021 Nov. 2021 Jan. 2022 Mar. 2022 May 2022 Total students 32,729 34,539 33,648 34,141 34,158 32,891 % change from prior year 1.6 % (2.8) % (2.1) % (4.5) % (4.3) % (5.8) % Chamberlain revenue increased 2.4%, or $13.5 million, to $571.0 million in fiscal year 2023 compared to the prior year, driven by an increase in fee revenue along with lower scholarships and discounts.
Results of Operations Revenue The following table presents revenue by segment detailing the changes from the prior year (in thousands): Year Ended June 30, 2024 Chamberlain Walden Medical and Veterinary Consolidated Fiscal year 2023 $ 571,034 $ 533,725 $ 346,067 $ 1,450,826 Growth 62,488 61,607 9,731 133,826 Fiscal year 2024 $ 633,522 $ 595,332 $ 355,798 $ 1,584,652 % change from prior year 10.9 % 11.5 % 2.8 % 9.2 % Chamberlain Chamberlain Student Enrollment: Fiscal Year 2024 Session July 2023 Sept. 2023 Nov. 2023 Jan. 2024 Mar. 2024 May 2024 Total students 32,175 34,889 35,592 37,196 37,985 36,750 % change from prior year 2.6 % 5.2 % 6.6 % 7.0 % 9.0 % 10.4 % Fiscal Year 2023 Session July 2022 Sept. 2022 Nov. 2022 Jan. 2023 Mar. 2023 May 2023 Total students 31,371 33,153 33,390 34,760 34,847 33,284 % change from prior year (4.1) % (4.0) % (0.8) % 1.8 % 2.0 % 1.2 % Chamberlain revenue increased 10.9%, or $62.5 million, to $633.5 million in fiscal year 2024 compared to the prior year, driven by an increase in enrollment and higher tuition rates.
Discussions throughout this MD&A are based on continuing operations unless otherwise noted. The MD&A should be read in conjunction with the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data” and the notes thereto. Segments We present three reportable segments as follows: Chamberlain – Offers degree and non-degree programs in the nursing and health professions postsecondary education industry.
Discussions throughout this MD&A are based on continuing operations unless otherwise noted. The MD&A should be read in conjunction with the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data” and the notes thereto. The following discussion is on the comparison between fiscal year 2024 and fiscal year 2023 results.
Adtalem had a surety-backed letter of credit outstanding of $84.0 million as of June 30, 2023 in favor of the ED on behalf of Walden, which allows Walden to participate in Title IV programs.
In addition, Adtalem had a letter of credit outstanding under its Revolver in the amount of $157.9 million as of June 30, 2024, in favor of ED, which allows Adtalem institutions to participate in Title IV programs. As of June 30, 2024, Adtalem had $227.3 million of letters of credit outstanding in favor of ED.
For students who entered RUSVM before September 2018, tuition rates for the pre-clinical and clinical curriculum are $21,069 and $26,449, respectively, per semester effective September 2022. All of these tuition rates represent a 5.0% increase from the prior academic year.
Effective for semesters beginning in September 2023, for students first enrolled in September 2018 and after, tuition rates for the pre-clinical and clinical curriculum of RUSVM’s veterinary program are $24,044 per semester. All of these tuition rates represent a 6.0% increase from the prior academic year.
The decrease in amortization expense is driven by the decrease in amortization relating to the student relationships intangible asset. This intangible asset is amortized based on the estimated retention of the students and considers the revenue and cash flow associated with these existing students, which are concentrated at the beginning of the asset’s useful life.
This intangible asset is amortized based on the estimated retention of the students and considers the revenue and cash flow associated with these existing students, which are concentrated at the beginning of the asset’s useful life. 43 Table of Contents Consolidated adjusted operating income increased 7.4%, or $21.2 million, to $308.8 million in fiscal year 2024 compared to the prior year.
Student Services and Administrative Expense The student services and administrative expense category includes expenses related to student admissions, marketing and advertising, general and administrative, and amortization expense of finite-lived intangible assets related to business acquisitions.
The decrease in the percentage was primarily the resul t of revenue growth accompanied with cost efficiencies. Student Services and Administrative Expense The student services and administrative expense category includes expenses related to student admissions, marketing and advertising, general and administrative, and amortization expense of acquired intangible assets.
Enrollment has begun to recover in several graduate and doctoral programs and the undergraduate Bachelor of Science-Nursing (“BSN”) programs. These improvements have been partially offset by a decrease in total student enrollment in the Registered Nurse to Bachelor of Science in Nursing (“RN-to-BSN”) online degree program.
Enrollment has improved in all graduate and doctoral programs and the undergraduate Bachelor of Science in Nursing (“BSN”) programs. In the March and May 2024 sessions, the Registered Nurse to Bachelor of Science in Nursing (“RN-BSN”) online degree program also saw increased total enrollment.
The following table presents student services and administrative expense by segment detailing the changes from the prior year (in thousands): Year Ended June 30, 2023 Chamberlain Walden Medical and Veterinary Home Office and Other Consolidated Fiscal year 2022 $ 175,516 $ 283,967 $ 67,436 $ 39,575 $ 566,494 Cost increase (decrease) 11,289 9,890 11,162 (7,748) 24,593 Effect of acquisitions — 27,152 — — 27,152 Intangible amortization expense — (36,035) — — (36,035) Litigation reserve — 10,000 — — 10,000 CEO transition costs — — — (6,195) (6,195) Fiscal year 2023 $ 186,805 $ 294,974 $ 78,598 $ 25,632 $ 586,009 Fiscal year 2023 % change: Cost increase 6.4 % 3.5 % 16.6 % NM 4.3 % Effect of acquisitions — 9.6 % — NM 4.8 % Effect of intangible amortization expense — (12.7) % — NM (6.4) % Effect of litigation reserve — 3.5 % — NM 1.8 % Effect of CEO transition costs — — — NM (1.1) % Fiscal year 2023 % change 6.4 % 3.9 % 16.6 % NM 3.4 % Student services and administrative expense increased 3.4%, or $19.5 million, to $586.0 million in fiscal year 2023 compared to the prior year.
The following table presents student services and administrative expense by segment detailing the changes from the prior year (in thousands): Year Ended June 30, 2024 Chamberlain Walden Medical and Veterinary Home Office Consolidated Fiscal year 2023 $ 186,805 $ 294,974 $ 78,598 $ 25,632 $ 586,009 Cost increase 31,702 19,940 5,470 5,444 62,556 Amortization of acquired intangible assets decrease — (25,595) — — (25,595) Litigation reserve increase — 8,500 — — 8,500 Loss on assets held for sale increase — — — 647 647 Debt modification costs increase — — — 848 848 Fiscal year 2024 $ 218,507 $ 297,819 $ 84,068 $ 32,571 $ 632,965 Fiscal year 2024 % change: Cost increase 17.0 % 6.8 % 7.0 % NM 10.7 % Amortization of acquired intangible assets decrease — (8.7) % — NM (4.4) % Litigation reserve increase — 2.9 % — NM 1.5 % Loss on assets held for sale increase — — — NM 0.1 % Debt modification costs increase — — — NM 0.1 % Fiscal year 2024 % change 17.0 % 1.0 % 7.0 % NM 8.0 % Student services and administrative expense increased 8.0%, or $47.0 million, to $633.0 million in fiscal year 2024 compared to the prior year.
As a percentage of revenue, student services and administrative expense was 40.4% in fiscal year 2023 compared to 41.0% in the prior year.
This cost increase was primarily driven by an increase in incentive compensation expense, marketing expense, and investments to support growth initiatives. As a percentage of revenue, student services and administrative expense was 39.9% in fiscal year 2024 compared to 40.4% in the prior year.
The capital expenditures in fiscal year 2023 primarily consisted of spending for Chamberlain’s new campus development and improvements and Adtalem’s home office, including information technology investments. Capital spending for fiscal year 2024 will support continued investment for new campus development at Chamberlain, maintenance at the medical and 67 Table of Contents veterinary schools, and information technology.
The capital expenditures in fiscal year 2024 primarily consisted of spending for information technology investments and Chamberlain’s campus development. For fiscal year 2025, we expect capital spending on information technology, new campus development at Chamberlain, and facility improvements at the medical and veterinary schools. Management anticipates fiscal year 2025 capital spending to be in the $55 to $75 million range.
The operating income reconciliation is included in the results of operations section within this MD&A. 73 Table of Contents Net income attributable to Adtalem reconciliation to adjusted net income (in thousands): Year Ended June 30, 2023 2022 2021 Net income attributable to Adtalem (GAAP) $ 93,358 $ 310,991 $ 70,027 Deferred revenue adjustment — 8,561 — CEO transition costs — 6,195 — Restructuring expense 18,817 25,628 6,869 Business acquisition and integration expense 42,661 53,198 31,593 Intangible amortization expense 61,239 97,274 — Gain on sale of assets (13,317) — — Pre-acquisition interest expense, write-off of debt discount and issuance costs, gain on extinguishment of debt, litigation reserve, and investment impairment 19,226 48,804 26,746 Net tax benefit related to a valuation allowance release (6,184) — — Income tax impact on non-GAAP adjustments (1) (31,997) (51,683) (16,297) Net loss (income) from discontinued operations attributable to Adtalem 8,394 (346,946) (6,579) Adjusted net income (non-GAAP) $ 192,197 $ 152,022 $ 112,359 (1) Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.
Net income reconciliation to adjusted net income (in thousands): Year Ended June 30, 2024 2023 Net income (GAAP) $ 136,777 $ 93,358 Restructuring expense 1,870 18,817 Business acquisition and integration expense 34,215 42,661 Amortization of acquired intangible assets 35,644 61,239 Gain on sale of assets — (13,317) Write-off of debt discount and issuance costs, gain on extinguishment of debt, litigation reserve, investment impairment, loss on assets held for sale, and debt modification costs 21,108 19,226 Tax benefit due to change in valuation allowance — (6,184) Tax benefit due to change in unrecognized tax benefits (5,657) — Income tax impact on non-GAAP adjustments (1) (23,104) (31,997) Loss from discontinued operations 936 8,394 Adjusted net income (non-GAAP) $ 201,789 $ 192,197 (1) Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.
The following table presents cost of educational services by segment detailing the changes from the prior year (in thousands): Year Ended June 30, 2023 Chamberlain Walden Medical and Veterinary Consolidated Fiscal year 2022 $ 254,768 $ 202,680 $ 202,328 $ 659,776 Cost decrease (6,041) (26,066) (2,194) (34,301) Effect of acquisitions — 23,011 — 23,011 Fiscal year 2023 $ 248,727 $ 199,625 $ 200,134 $ 648,486 Fiscal year 2023 % change: Cost decrease (2.4) % (12.9) % (1.1) % (5.2) % Effect of acquisitions — 11.4 % — 3.5 % Fiscal year 2023 % change (2.4) % (1.5) % (1.1) % (1.7) % Cost of educational services decreased 1.7%, or $11.3 million, to $648.5 million in fiscal year 2023 compared to the prior year.
The following table presents cost of educational services by segment detailing the changes from the prior year (in thousands): Year Ended June 30, 2024 Chamberlain Walden Medical and Veterinary Consolidated Fiscal year 2023 $ 248,727 $ 199,625 $ 200,134 $ 648,486 Cost increase 28,488 21,485 89 50,062 Fiscal year 2024 $ 277,215 $ 221,110 $ 200,223 $ 698,548 % change from prior year 11.5 % 10.8 % 0.0 % 7.7 % Cost of educational services increased 7.7%, or $50.1 million, to $698.5 million in fiscal year 2024 compared to the prior year.
“Financial Statements and Supplementary Data.” Operating Income The following table presents operating income by segment detailing the changes from the prior year (in thousands): Year Ended June 30, 2023 Chamberlain Walden Medical and Veterinary Home Office and Other Consolidated Fiscal year 2022 $ 124,414 $ (5,306) $ 59,357 $ (101,719) $ 76,746 Organic change 8,251 (8,206) (1,812) 7,747 5,980 Effect of acquisitions — 13,988 — — 13,988 Deferred revenue adjustment change — 8,561 — — 8,561 CEO transition costs change — — — 6,195 6,195 Restructuring expense change 2,020 808 2,104 1,879 6,811 Business acquisition and integration expense change — — — 10,537 10,537 Intangible amortization expense change — 36,035 — — 36,035 Litigation reserve change — (10,000) — — (10,000) Gain on sale of assets change — — — 13,317 13,317 Fiscal year 2023 $ 134,685 $ 35,880 $ 59,649 $ (62,044) $ 168,170 55 Table of Contents The following table presents a reconciliation of operating income (GAAP) to adjusted operating income (non-GAAP) by segment (in thousands): Year Ended June 30, Increase/(Decrease) 2023 2022 $ % Chamberlain: Operating income (GAAP) $ 134,685 $ 124,414 $ 10,271 8.3 % Restructuring expense 818 2,838 (2,020) Adjusted operating income (non-GAAP) $ 135,503 $ 127,252 $ 8,251 6.5 % Operating margin (GAAP) 23.6 % 22.3 % Operating margin (non-GAAP) 23.7 % 22.8 % Walden: Operating income (loss) (GAAP) $ 35,880 $ (5,306) $ 41,186 NM Deferred revenue adjustment — 8,561 (8,561) Restructuring expense 3,245 4,053 (808) Intangible amortization expense 61,239 97,274 (36,035) Litigation reserve 10,000 — 10,000 Adjusted operating income (non-GAAP) $ 110,364 $ 104,582 $ 5,782 5.5 % Operating margin (GAAP) 6.7 % (1.1) % Operating margin (non-GAAP) 20.7 % 21.5 % Medical and Veterinary: Operating income (GAAP) $ 59,649 $ 59,357 $ 292 0.5 % Restructuring expense 7,687 9,791 (2,104) Adjusted operating income (non-GAAP) $ 67,336 $ 69,148 $ (1,812) (2.6) % Operating margin (GAAP) 17.2 % 17.5 % Operating margin (non-GAAP) 19.5 % 20.4 % Home Office and Other: Operating loss (GAAP) $ (62,044) $ (101,719) $ 39,675 39.0 % CEO transition costs — 6,195 (6,195) Restructuring expense 7,067 8,946 (1,879) Business acquisition and integration expense 42,661 53,198 (10,537) Gain on sale of assets (13,317) — (13,317) Adjusted operating loss (non-GAAP) $ (25,633) $ (33,380) $ 7,747 23.2 % Adtalem Global Education: Operating income (GAAP) $ 168,170 $ 76,746 $ 91,424 119.1 % Deferred revenue adjustment — 8,561 (8,561) CEO transition costs — 6,195 (6,195) Restructuring expense 18,817 25,628 (6,811) Business acquisition and integration expense 42,661 53,198 (10,537) Intangible amortization expense 61,239 97,274 (36,035) Litigation reserve 10,000 — 10,000 Gain on sale of assets (13,317) — (13,317) Adjusted operating income (non-GAAP) $ 287,570 $ 267,602 $ 19,968 7.5 % Operating margin (GAAP) 11.6 % 5.6 % Operating margin (non-GAAP) 19.8 % 19.4 % Consolidated operating income increased 119.1%, or $91.4 million, to $168.2 million in fiscal year 2023 compared to the prior year.
“Financial Statements and Supplementary Data.” 42 Table of Contents Operating Income The following table presents a reconciliation of operating income (GAAP) to adjusted operating income (non-GAAP) by segment (in thousands): Year Ended June 30, Increase/(Decrease) 2024 2023 $ % Chamberlain: Operating income (GAAP) $ 137,800 $ 134,685 $ 3,115 2.3 % Restructuring expense — 818 (818) Adjusted operating income (non-GAAP) $ 137,800 $ 135,503 $ 2,297 1.7 % Operating margin (GAAP) 21.8 % 23.6 % Operating margin (non-GAAP) 21.8 % 23.7 % Walden: Operating income (GAAP) $ 77,179 $ 35,880 $ 41,299 115.1 % Restructuring expense (776) 3,245 (4,021) Amortization of acquired intangible assets 35,644 61,239 (25,595) Litigation reserve 18,500 10,000 8,500 Adjusted operating income (non-GAAP) $ 130,547 $ 110,364 $ 20,183 18.3 % Operating margin (GAAP) 13.0 % 6.7 % Operating margin (non-GAAP) 21.9 % 20.7 % Medical and Veterinary: Operating income (GAAP) $ 71,065 $ 59,649 $ 11,416 19.1 % Restructuring expense 442 7,687 (7,245) Adjusted operating income (non-GAAP) $ 71,507 $ 67,336 $ 4,171 6.2 % Operating margin (GAAP) 20.0 % 17.2 % Operating margin (non-GAAP) 20.1 % 19.5 % Home Office: Operating loss (GAAP) $ (68,990) $ (62,044) $ (6,946) (11.2) % Restructuring expense 2,204 7,067 (4,863) Business acquisition and integration expense 34,215 42,661 (8,446) Loss on assets held for sale 647 — 647 Debt modification costs 848 — 848 Gain on sale of assets — (13,317) 13,317 Adjusted operating loss (non-GAAP) $ (31,076) $ (25,633) $ (5,443) (21.2) % Adtalem Global Education: Operating income (GAAP) $ 217,054 $ 168,170 $ 48,884 29.1 % Restructuring expense 1,870 18,817 (16,947) Business acquisition and integration expense 34,215 42,661 (8,446) Amortization of acquired intangible assets 35,644 61,239 (25,595) Litigation reserve 18,500 10,000 8,500 Loss on assets held for sale 647 — 647 Debt modification costs 848 — 848 Gain on sale of assets — (13,317) 13,317 Adjusted operating income (non-GAAP) $ 308,778 $ 287,570 $ 21,208 7.4 % Operating margin (GAAP) 13.7 % 11.6 % Operating margin (non-GAAP) 19.5 % 19.8 % Consolidated operating income increased 29.1%, or $48.9 million, to $217.1 million in fiscal year 2024 compared to the prior year.
These tuition rates represented a 2.4% increase from the prior academic year. ● For students who entered the RUSVM program in September 2018 or later, the tuition rate for the pre-clinical (Semesters 1-7) and clinical curriculum (Semesters 8-10) was $21,603 per semester effective September 2021.
These tuition rates and fees represent a 6.0% increase from the prior academic year. ● Effective for semesters beginning in September 2023, for students who first enrolled prior to September 2018, tuition rates for the pre-clinical (semesters 1-7) and clinical curriculum (semesters 8-10) of RUSVM’s veterinary program are $22,334 and $28,034, respectively, per semester.
This segment includes the operations of the American University of the Caribbean School of Medicine (“AUC”), Ross University School of Medicine (“RUSM”), and Ross University School of Veterinary Medicine (“RUSVM”), which are collectively referred to as the “medical and veterinary schools.” “Home Office and Other” includes activities not allocated to a reportable segment.
Medical and Veterinary – Offers degree and certificate programs in the medical and veterinary postsecondary education industry. This segment includes the operations of AUC, RUSM, and RUSVM, which are collectively referred to as the “medical and veterinary schools.” “Home Office” includes activities not allocated to a reportable segment.
We do not include normal, recurring, cash operating expenses in our business acquisition and integration expense. ● Intangible amortization expense on acquired intangible assets. ● Gain on sale of Adtalem’s Chicago, Illinois, campus facility. ● Pre-acquisition interest expense related to financing arrangements in connection with the Walden acquisition, write-off of debt discount and issuance costs and gain on extinguishment of debt related to prepayments of debt, reserves related to significant litigation, and impairment of an equity investment. ● Net tax benefit related to a valuation allowance release. ● Net loss (income) from discontinued operations attributable to Adtalem includes the operations of ACAMS, Becker, OCL, and EduPristine, including the after-tax gain on the sale of these businesses, in addition to costs related to DeVry University.
We do not include normal, recurring, cash operating expenses in our business acquisition and integration expense. ● Amortization of acquired intangible assets. ● Amortization of cloud computing implementation assets. ● Gain on sale of Adtalem’s Chicago, Illinois, campus facility. ● Write-off of debt discount and issuance costs and gain on extinguishment of debt related to prepayments of debt, reserves related to significant litigation, impairment of an equity investment, loss on assets held for sale related to a fair value write-down on assets, and debt modification costs related to refinancing our Term Loan B loan. ● Tax benefit due to change in valuation allowance. ● Tax benefit due to change in unrecognized tax benefits. ● Loss from discontinued operations includes expense from ongoing litigation costs and settlements related to the DeVry University and Carrington College divestitures, a loss on sale of ACAMS, Becker, and OCL for working capital adjustments to the initial sales prices and a tax return to provision adjustment, and the earn-outs we received. 50 Table of Contents The following tables provide a reconciliation from the most directly comparable GAAP measure to these non-GAAP financial measures.